Home  »  Companies   »  ChromaDex Corporation (CDXC): When Right, Sit Tigh...

ChromaDex Corporation (CDXC): When Right, Sit Tight

ChromaDex Corporation (NASDAQ:CDXC) at last check was buoying at $1.99 on Friday, May 20 with a rise of 13.07% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $1.76 and 5Y monthly beta was reading 1.78 with its price kept floating in the range of $1.71 and $1.82 on the day. Considering stock’s 52-week price range provides that CDXC hit a high price of $10.78 and saw its price falling to a low level of $1.51 during that period. Over a period of past 1-month, stock came subtracting -18.89% in its value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


With its current market valuation of $116.74 million, ChromaDex Corporation is set to declare its quarterly results on Aug 01, 2022 – Aug 05, 2022. Analysts are in estimates of -$0.08 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.34 for 2022 with estimates of that growing to -$0.22 in next year. These estimates are suggesting current year growth of 15.00% for EPS and 35.30% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $18.58 million. They suggested that in the process company could generate revenue of as low as $16.07 million which could climb up to $19.8 million to hit a high. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $78.35 million in 2022, which will be 16.20% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with 1 upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review CDXC stock’s current outlook then short term indicators are assigning it an average of 50% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.

Digging deeper we become aware of the PEG ratio of the CDXC stock which is currently positioned at 0. It further provides that stock’s current price level is 9.04% away from its 20-day simple moving average and is -7.24% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 52.66 while volatility remained at 10.89% over the past week which changes to 8.69% when measuring it over the past month. Beta is valued at 1.80, while measure of average true range or ATR is currently at 0.16.

In comparing ChromaDex Corporation (CDXC)’s stock with other industry players reveals that stock’s latest price change of 13.07% and that of -77.69% over the past 12 months is in competing position with that of Sangamo Therapeutics Inc. (SGMO) which saw its stock price raised by 3.62% in the recent trading and went through a decrease of -63.44% in past 12-month trading. Industry’s another major player Natural Alternatives International Inc. (NAII) has fall -0.49% down in latest trading session, but over the past year has faced afall of -29.99%, while Exelixis Inc. (EXEL) was also up 1.23% however its price remained floating in the red at -28.32% over the same period. ChromaDex Corporation has a P/E ratio of 0 while Natural Alternatives International Inc. is showing 6.46 for the same. On the other hand, the S&P 500 Index is down -0.47% in the early deals today while the Dow Jones Industrial was dealinglower at -0.56%.

Having a second look at ChromaDex Corporation (NASDAQ:CDXC) provides that stock’s average daily trading volume for 3 months was 472.02K. Number of outstanding shares of the stock stood at 66.33 million.

The percentage of outstanding shares held by the insiders is 1.30% while it is 32.50% for the institutional holders. Subtraction of -52.94% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts